MedPath

Proxalutamide

Generic Name
Proxalutamide
Drug Type
Small Molecule
Chemical Formula
C24H19F4N5O2S
CAS Number
1398046-21-3
Unique Ingredient Identifier
QX6O64GP40
Background

Proxalutamide is under investigation in clinical trial NCT03899467 (The Safety and Tolerability of Proxalutamide (GT0918) in Subjects With Metastatic Castrate Resistant Prostate Cancer).

Indication

用于转移性去势抵抗性前列腺癌(mCRPC)和转移性乳腺癌患者的治疗。

© Copyright 2025. All Rights Reserved by MedPath